Ixekizumab Survival in Heavily Pretreated Patients with Psoriasis: A Two-year Single-centre Retrospective Study

• Main Authors: Shany Sherman (Author), Ory Zloczower (Author), Yehonatan Noyman (Author), Iris Amitay-Laish (Author), Emmilia Hodak (Author), Lev Pavlovsky (Author)
• Format: Book
• Published: Medical Journals Sweden, 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The long-term effect of intra-anti-interleukin-17-class switch on drug survival is unclear. The aim of this study was to evaluate the efficacy and long-term survival of ixekizumab in bio-experienced psoriatic patients with and without previous exposure to anti-interleukin-17 treatment. Retrospective...